Bioinformatics companies in Massachusetts are at the intersection of biology and technology, utilizing computational methods to solve complex biological data challenges. These firms provide essential services such as genomic data analysis, predictive modeling, and drug discovery, which are pivotal in transforming healthcare and life sciences. With the increasing volume of biological data generated daily, there's a notable shift towards leveraging artificial intelligence and machine learning to enhance research efficiency and outcomes. The sector is poised for growth, driven by advancements in personalized medicine and a heightened focus on leveraging data for innovative solutions to health challenges.

The companies highlighted herein represent a blend of small nimble startups and more substantial firms, all situated in prominent Massachusetts locales like Boston and Cambridge. Founded between 2000 to 2023, these businesses focus on specialties from genomic profiling to molecular diagnostics. Sizes range from teams of under ten to several thousand employees, demonstrating a wide spectrum of operational scale and capability. The array of innovative solutions they provide supports the burgeoning need for precision diagnostics and advanced therapeutic strategies, enabling a proactive approach to modern healthcare.

Read on to discover the top bioinformatics companies in Massachusetts.

Top 23 Bioinformatics Companies Companies in Massachusetts

1. Seven Bridges

• Website: sevenbridges.com
• Ownership type: Venture Capital
• Headquarters: Boston, Massachusetts, United States (USA)
• Latest funding: Series C, $15.0M, April 2021
• Founded year: 2009
• Headcount: 201-500
• LinkedIn: seven-bridges-inc

Seven Bridges is a Boston-based biomedical data company founded in 2009. It specializes in software and data analytics aimed at enhancing healthcare research. The company provides bioinformatics solutions, particularly tools for genomic data analysis, which are crucial for biopharma companies and research institutions. Their services facilitate the development of new treatments and diagnostics. Seven Bridges has developed a cloud-based platform that allows researchers to access public datasets and bioinformatics tools, streamlining the process from raw data to actionable insights. In April 2021, they raised $15 million in Series C funding, underscoring their growth and commitment to advancing genomic research. Recently, they have rebranded as Velsera, expanding their offerings to include integrated solutions for healthcare research.

2. Data4Cure, Inc.

• Website: data4cure.com
• Ownership type: Private
• Headquarters: Waltham, Massachusetts, United States (USA)
• Employee distribution: Poland 75%, United States (USA) 25%
• Founded year: 2013
• Headcount: 11-50
• LinkedIn: data4cure

Data4Cure, Inc., founded in 2013 and based in Waltham, Massachusetts, is a private company that specializes in biomedical data analysis. With a team of approximately 24 employees, the company provides advanced solutions aimed at enhancing drug development and clinical research processes. Their offerings include omics data management, clinical trial analysis, and predictive modeling, primarily catering to pharmaceutical companies and research organizations. Data4Cure leverages cutting-edge bioinformatics and machine learning technologies to convert complex datasets into actionable insights. Their platform, known as the Biomedical Intelligence® Cloud, integrates thousands of public omics, phenotypic, and clinical datasets, facilitating comprehensive analysis and knowledge synthesis. This integration supports critical decision-making throughout the drug development process, making Data4Cure a significant player in the bioinformatics field.

3. Vizgen

• Website: vizgen.com
• Ownership type: Venture Capital
• Headquarters: Cambridge, Massachusetts, United States (USA)
• Employee distribution: United States (USA) 89%, United Kingdom (UK) 4%, Singapore 2%, Other 5%
• Latest funding: Series D, October 2024
• Founded year: 2019
• Headcount: 51-200
• LinkedIn: vizgen

Vizgen, founded in 2019 and based in Cambridge, Massachusetts, is a biotechnology company that focuses on spatial genomics and transcriptomics. The company offers advanced products like the MERSCOPE Ultra™ platform, which automates sample imaging and analysis, allowing researchers to explore gene expression and cellular interactions in detail. Their technologies are particularly applicable in neuroscience and oncology, providing essential tools for understanding complex biological systems. Vizgen also provides lab services, enabling researchers to leverage their expertise in spatial profiling and MERFISH technology. The company has recently merged with Ultivue, enhancing its capabilities and market presence. With a workforce of around 123 employees, Vizgen is positioned to make significant contributions to scientific research and discovery in the bioinformatics field.

4. Ovation

• Website: ovation.io
• Ownership type: Venture Capital
• Headquarters: Cambridge, Massachusetts, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Series B, $21.5M, December 2020
• Founded year: 2017
• Headcount: 11-50
• LinkedIn: ovation-io

Ovation is a genomic data company based in Cambridge, Massachusetts, founded in 2017. The company specializes in providing high-quality genomic data and laboratory services tailored for life sciences researchers and biopharma companies. Their mission is to accelerate drug discovery and development through innovative solutions, including a cloud-based laboratory information management system (LIMS) and extensive biobank services. Ovation's offerings include genomic data products, lab integrations, and pathogen data, which are essential for supporting clinical laboratories and research networks. With a biobank of approximately 1.6 million consented samples, Ovation is well-positioned to facilitate research across various therapeutic areas. The company has successfully raised $21.5 million in funding, demonstrating its growth potential and commitment to advancing human health through molecular and genomic data.

5. Fulcrum Genomics LLC

• Website: fulcrumgenomics.com
• Ownership type: Private
• Headquarters: Somerville, Massachusetts, United States (USA)
• Employee distribution: United States (USA) 62%, Canada 38%
• Founded year: 2015
• Headcount: 11-50
• LinkedIn: fulcrum-genomics

Fulcrum Genomics LLC, based in Somerville, Massachusetts, is a bioinformatics consulting company founded in 2015. The firm specializes in creating innovative tools and systems for the analysis of biological data. With a team of skilled bioinformaticians, computational biologists, and software engineers, Fulcrum Genomics collaborates with a variety of clients, including startups and major pharmaceutical firms. Their services focus on modernizing data analysis processes and providing insights that drive scientific discovery and product development. The company has successfully completed numerous projects, demonstrating their ability to adapt to the evolving needs of the life sciences sector. Fulcrum Genomics is dedicated to helping clients navigate the complexities of bioinformatics, ensuring that they can effectively leverage their data for research and clinical applications.

6. Genuity Science

• Website: genuitysci.com
• Ownership type: Corporate
• Headquarters: Boston, Massachusetts, United States (USA)
• Latest funding: August 2021
• Founded year: 2013
• Headcount: 201-500
• LinkedIn: genuity-science

Genuity Science (Ireland) Limited is a life sciences company based in Boston, Massachusetts, with a focus on genomic research and precision medicine. Founded in 2013, the company has carved out a niche in the healthcare and biotechnology sectors by offering services that include target discovery, clinical trials, and comprehensive data analysis. Genuity Science collaborates with various stakeholders, including clinics, universities, and commercial partners, to enhance the processes of drug discovery and development. Their work involves building a robust database of genomic and health-related data, which is utilized to drive insights into the relationship between genetics, health, and disease. The company is particularly noted for its expertise in managing large, population-scale datasets and applying advanced analytical techniques to support their clients' research objectives.

7. NanoMosaic Inc.

• Website: nanomosaicllc.com
• Ownership type: Venture Capital
• Headquarters: Waltham, Massachusetts, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Series A, $40.8M, December 2021
• Founded year: 2018
• Headcount: 11-50
• LinkedIn: nanomosaic

NanoMosaic Inc., founded in 2018 and based in Waltham, Massachusetts, is a biotechnology firm that specializes in molecular profiling and gene therapy applications. The company has developed innovative technologies, including NanoNeedles and the Tessie platform, which facilitate the analysis of proteins and nucleic acids. These products are designed to meet the needs of biotechnology and pharmaceutical companies, providing advanced solutions for research and development in gene therapies and diagnostics. With a recent Series A funding round of $40.75 million in December 2021, NanoMosaic is positioned to further its impact in the industry, particularly in areas such as neurology and immunology. Their commitment to improving molecular analysis workflows highlights their relevance in the bioinformatics sector.

8. BioSymetrics

• Website: biosymetrics.com
• Ownership type: Corporate
• Headquarters: Boston, Massachusetts, United States (USA)
• Employee distribution: Canada 61%, United States (USA) 39%
• Latest funding: February 2025
• Founded year: 2015
• Headcount: 11-50
• LinkedIn: biosymetrics

BioSymetrics is a biotechnology firm based in Boston, Massachusetts, founded in 2015. The company specializes in drug discovery and development, leveraging machine learning and phenomics to identify high-confidence targets for precision medicines. Their focus areas include neurological, cardiometabolic, and rare diseases, with a notable emphasis on conditions such as epilepsy and familial dilated cardiomyopathy. BioSymetrics operates a platform called Elion, which integrates clinical data from millions of electronic medical records with experimental data from zebrafish models. This innovative approach allows them to make predictions about potential drug targets and validate these predictions through in vivo experiments. The company collaborates with pharmaceutical companies and research organizations to enhance drug discovery processes, making significant contributions to the field of bioinformatics through their data-driven methodologies.

9. Insilico Medicine

• Website: insilico.com
• Ownership type: Private Equity
• Headquarters: Boston, Massachusetts, United States (USA)
• Employee distribution: China 43%, United Arab Emirates 20%, Hong Kong S.A.R 18%, Other 19%
• Latest funding: Series E-K, $110.0M, March 2025
• Founded year: 2014
• Headcount: 201-500
• LinkedIn: in-silico-medicine-inc

Insilico Medicine is a biotechnology firm based in Boston, Massachusetts, founded in 2014. The company specializes in drug discovery and development, leveraging artificial intelligence to streamline and enhance pharmaceutical research. Insilico offers a suite of AI-driven platforms, including PHARMA.AI, which facilitate multi-omics target discovery and deep biological analysis. Their primary clientele consists of pharmaceutical companies and research institutions seeking innovative solutions to expedite drug development. Insilico operates on a global scale, with a significant presence in regions such as China, the United Arab Emirates, and Hong Kong. The company has successfully raised $110 million in its Series E-K funding round, underscoring its growth and the confidence investors have in its AI-driven methodologies. Insilico's pipeline includes numerous preclinical candidates, showcasing its commitment to advancing drug candidates from concept to clinical trials.

10. Matterworks

• Website: matterworks.ai
• Ownership type: Venture Capital
• Headquarters: Somerville, Massachusetts, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Seed, $7.5M, August 2023
• Founded year: 2019
• Headcount: 11-50
• LinkedIn: matterworksbio

Matterworks, founded in 2019 and based in Somerville, Massachusetts, is a biotechnology firm that specializes in AI-driven solutions for the analysis of biological data. The company has developed the Large Spectral Model (LSM), which allows for the interpretation of complex omic data that is often discarded due to its unstructured nature. Their flagship product, Pyxis, leverages this technology to provide rapid and accurate quantitation of biological samples, catering to researchers and organizations in the life sciences sector. Matterworks has recently secured $7.5 million in seed funding, reflecting strong investor interest in their innovative approach to biological data analysis. The company aims to enhance research capabilities and outcomes through its advanced tools, which are applicable in areas such as bioprocessing, biomarker discovery, and drug development.

11. BioTeam, LLC

• Website: bioteam.net
• Ownership type: Corporate
• Headquarters: Middleton, Massachusetts, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: August 2024
• Founded year: 2002
• Headcount: 11-50
• LinkedIn: the-bioteam

BioTeam, LLC, founded in 2002 and based in Middleton, Massachusetts, is a consulting firm that specializes in life sciences IT solutions. With a team of 31 employees, BioTeam focuses on enhancing research capabilities and data management for clients across academia, biotech, government, and non-profit sectors. Their services include building scientific data ecosystems, advanced networking, high-performance computing, and data governance. BioTeam is dedicated to helping organizations manage and utilize their data effectively, ensuring that scientists can conduct research without the hindrance of data silos. They have a holistic approach to IT solutions, which involves assessing, strategizing, designing, and supporting scientific data environments. Their commitment to bioinformatics is evident in their practice areas, which include data science and bioinformatics, making them a valuable partner for organizations looking to accelerate scientific discovery.

12. New England Biolabs

• Website: neb.com
• Ownership type: Private
• Headquarters: Ipswich, Massachusetts, United States (USA)
• Employee distribution: United States (USA) 81%, United Kingdom (UK) 6%, Canada 3%, Other 10%
• Latest funding: $1.2M, September 2010
• Founded year: 1974
• Headcount: 501-1000
• LinkedIn: new-england-biolabs

New England Biolabs (NEB), founded in 1974 and based in Ipswich, Massachusetts, is a private biotechnology company that specializes in the life sciences sector. With a workforce of approximately 780 employees, NEB produces a wide array of enzyme reagents and tools that are integral to genome editing, synthetic biology, and next-generation sequencing. The company serves a global clientele of researchers and organizations, providing essential products that facilitate scientific inquiry and innovation. NEB is known for its commitment to advancing science and environmental stewardship, and it actively engages in research and development to enhance its product offerings. Their extensive catalog includes specialized kits and reagents that support various applications in molecular biology, making them a key player in the biotechnology industry.

13. Quantori

• Website: quantori.com
• Ownership type: Venture Capital
• Headquarters: Cambridge, Massachusetts, United States (USA)
• Employee distribution: Armenia 36%, Georgia 23%, United States (USA) 15%, Other 26%
• Latest funding: Seed, $15.0M, July 2022
• Founded year: 2018
• Headcount: 501-1000
• LinkedIn: quantori

Quantori, founded in 2018 and based in Cambridge, Massachusetts, is a for-profit company that specializes in life sciences IT solutions. With a workforce of over 500 employees, the company focuses on providing scientific informatics, laboratory informatics, and data science services tailored to the needs of biotech and pharmaceutical clients. Their mission is to enhance drug discovery and development processes through custom software solutions and advanced data management techniques. Quantori has worked on over 1,000 projects, showcasing its extensive experience in the field. The company has also received significant funding, with a recent seed round of $15 million in July 2022, indicating investor confidence in its business model and growth trajectory. Quantori's expertise in cloud engineering, artificial intelligence, and high-performance computing further positions it as a key player in the bioinformatics sector, making meaningful contributions to the advancement of healthcare and life sciences.

14. TileDB

• Website: tiledb.com
• Ownership type: Venture Capital
• Headquarters: Cambridge, Massachusetts, United States (USA)
• Employee distribution: United States (USA) 75%, Greece 14%, Netherlands 5%, Other 5%
• Latest funding: Series B, $34.0M, September 2023
• Founded year: 2017
• Headcount: 51-200
• LinkedIn: tiledb-inc

TileDB, Inc., founded in 2017 and based in Cambridge, Massachusetts, specializes in innovative data management solutions for scientific research. The company offers TileDB Cloud, a platform designed to facilitate the cataloging, collaboration, and analysis of complex data types, with a particular emphasis on genomics and single-cell analysis. TileDB's technology is utilized by pharmaceutical companies and research institutions that require efficient data handling to enhance their research and development processes. The platform supports a variety of data types, including genomic variants and biomedical imaging, making it a versatile tool for bioinformatics applications. TileDB has garnered attention for its partnerships with organizations like Quest Diagnostics, which is building a multi-omics data mesh using TileDB, and Rady Children's Hospital, which employs the platform for expanded newborn screening and genetic diagnosis. In September 2023, TileDB raised $34 million in a Series B funding round, further solidifying its position in the industry and enabling continued innovation in data management for scientific discovery.

15. Foundation Medicine

• Website: foundationmedicine.com
• Ownership type: Corporate
• Headquarters: Boston, Massachusetts, United States (USA)
• Employee distribution: United States (USA) 95%, Germany 3%, Other 1%
• Latest funding: $2.4B, January 2015
• Founded year: 2010
• Headcount: 1001-5000
• LinkedIn: foundation-medicine

Foundation Medicine, Inc., founded in 2010 and based in Boston, Massachusetts, is a biotechnology company that specializes in genomic profiling for cancer treatment. The company offers a range of genomic tests, including FoundationOne CDx and FoundationOne Liquid CDx, which analyze genetic alterations in cancer patients. These tests provide healthcare providers, biopharmaceutical companies, and researchers with actionable insights that facilitate targeted therapies and clinical trial enrollment. Foundation Medicine has developed a robust database, FoundationCore®, which is one of the largest cancer genomic databases globally. This database supports their testing services and aids in the discovery of new therapies. The company has also been involved in numerous clinical trials and has a strong track record of FDA-approved companion diagnostics, making it a key player in the intersection of genomics and oncology.

16. BostonGene

• Website: bostongene.com
• Ownership type: Private Equity
• Headquarters: Waltham, Massachusetts, United States (USA)
• Employee distribution: Armenia 74%, United States (USA) 18%, Russia 6%
• Latest funding: Series B, $150.0M, April 2022
• Founded year: 2015
• Headcount: 501-1000
• LinkedIn: bostongene

BostonGene, founded in 2015 and based in Waltham, Massachusetts, is a biotechnology firm focused on personalized medicine and cancer diagnostics. The company offers advanced molecular and immune profiling services designed to assist healthcare providers and patients in selecting the most effective treatment options. Their innovative technologies are utilized by cancer patients, healthcare providers, and biopharma companies, aiming to improve patient outcomes. BostonGene operates a state-of-the-art molecular testing laboratory that employs next-generation sequencing technologies. Their cloud-based software platform integrates bioinformatics capabilities, allowing for comprehensive analysis of genomic, transcriptomic, and microenvironment data. In April 2022, BostonGene secured $150 million in Series B funding, underscoring its growth potential and commitment to advancing precision medicine. The company collaborates with notable cancer centers, including MD Anderson Cancer Center and Dana-Farber Cancer Institute, to enhance cancer diagnostics and treatment strategies. BostonGene's focus on AI-driven solutions and its recognition through various awards highlight its role in transforming cancer care through precision diagnostics.

17. Gns

• Website: gnshealthcare.com
• Ownership type: Venture Capital
• Headquarters: Somerville, Massachusetts, United States (USA)
• Latest funding: $23.0M, July 2019
• Founded year: 2000
• Headcount: 51-200
• LinkedIn: gns-healthcare

Aitia, formerly known as Gns, is a biotechnology firm based in Somerville, Massachusetts, founded in 2000. The company specializes in AI-driven drug discovery and development, utilizing causal AI and Gemini Digital Twins to uncover hidden biological mechanisms. Their innovative approach aims to accelerate the creation of breakthrough drugs, particularly targeting neurodegenerative diseases and oncology. Aitia collaborates with pharmaceutical companies and healthcare organizations, providing them with advanced solutions for drug development. The company has received significant funding, with a reported amount of $23 million in July 2019, which supports their ongoing research and development efforts in the biotech sector.

18. Velsera

• Website: velsera.com
• Ownership type: Private
• Headquarters: Boston, Massachusetts, United States (USA)
• Employee distribution: India 52%, Serbia 24%, United States (USA) 15%, Other 9%
• Founded year: 2023
• Headcount: 501-1000
• LinkedIn: velseraofficial

Velsera, based in Boston, Massachusetts, is a private company founded in 2023 that specializes in genomics solutions with a focus on precision medicine and bioinformatics. The company provides advanced tools and platforms designed for genomic analysis, clinical interpretation, and reporting. Their offerings are primarily aimed at clinical laboratories and pharmaceutical companies, enhancing their capabilities in data analysis and improving patient outcomes. Velsera's business model emphasizes scalable, cloud-based solutions, which are increasingly important in the healthcare sector. The company operates with a global workforce, with a significant portion of its employees located in India and Serbia, reflecting its commitment to leveraging talent across borders. Velsera's technology is designed to streamline lab workflows and automate data analysis, making it a valuable partner in the healthcare and life sciences ecosystem.

19. Sherlock Biosciences

• Website: sherlock.bio
• Ownership type: Venture Capital
• Headquarters: Boston, Massachusetts, United States (USA)
• Employee distribution: United States (USA) 61%, United Kingdom (UK) 39%
• Latest funding: Other (Grant), November 2022
• Founded year: 2019
• Headcount: 11-50
• LinkedIn: sherlock-biosciences

Sherlock Biosciences, founded in 2019 and based in Boston, Massachusetts, is a biotechnology firm specializing in molecular diagnostics. The company leverages cutting-edge technologies, including CRISPR and synthetic biology, to create diagnostic tests that provide rapid and accurate health information. Their products are designed for both healthcare providers and consumers, aiming to democratize access to reliable testing solutions for disease detection and health management. Sherlock has developed proprietary platforms such as SHERLOCK™ and INSPECTR™, which enable precise detection of DNA and RNA in various settings. The company has also received a grant to support its initiatives, reflecting its commitment to advancing healthcare solutions. With a focus on global health equity, Sherlock Biosciences actively collaborates with health organizations to enhance diagnostic capabilities, particularly in low-resource environments.

20. Tagomics

• Website: tagomics.com
• Ownership type: Venture Capital
• Headquarters: Cambridge, Massachusetts, United States (USA)
• Employee distribution: United Kingdom (UK) 100%
• Latest funding: Seed, $8.5M, February 2024
• Founded year: 2020
• Headcount: 1-10
• LinkedIn: tagomics

Tagomics, founded in 2020 and based in Cambridge, Massachusetts, is a biotechnology firm specializing in multiomic profiling for disease diagnosis. The company aims to transform how diseases, especially cancer, are diagnosed by utilizing a proprietary platform that integrates epigenomic, genomic, and fragmentomic analyses. This comprehensive approach allows for the identification of biomarkers associated with various diseases, enhancing the understanding and treatment strategies for healthcare providers and researchers. Tagomics has recently raised £6.7 million in funding, which will support its scientific research and product development efforts. The company emerged from the University of Birmingham, building on pivotal research led by its Chief Scientific Officer, Dr. Robert Neely. With a small but dedicated team, Tagomics is positioned to make significant contributions to the field of bioinformatics and clinical diagnostics.

21. Dotmatics

• Website: dotmatics.com
• Ownership type: Corporate
• Headquarters: Boston, Massachusetts, United States (USA)
• Employee distribution: United States (USA) 42%, United Kingdom (UK) 30%, New Zealand 11%, Other 17%
• Latest funding: $5.1B, April 2025
• Founded year: 2005
• Headcount: 501-1000
• LinkedIn: dotmatics

Dotmatics is a scientific software company based in Boston, Massachusetts, founded in 2005. With a workforce of around 615 employees, the company has established itself as a provider of comprehensive solutions for research and development in the life sciences and biotechnology sectors. Dotmatics offers the Luma Scientific Intelligence Platform, which integrates data management and workflow automation, enabling scientists to streamline their research processes. Their software includes tools for sequence analysis, data visualization, and electronic lab notebooks, all of which are crucial for bioinformatics applications. Dotmatics serves a wide range of clients, helping them accelerate their research efforts and improve collaboration. The company has also secured significant funding, indicating strong investor confidence in its growth and potential impact in the industry.

22. Oligo Factory

• Website: oligofactory.com
• Ownership type: Private
• Headquarters: Holliston, Massachusetts, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2006
• Headcount: 11-50
• LinkedIn: oligo-factory

Oligo Factory, founded in 2006 and based in Holliston, Massachusetts, is a biotechnology company that specializes in the custom synthesis of DNA and RNA oligonucleotides. With a team of skilled professionals, including chromatographers and synthesis chemists, the company has built a reputation for delivering high-quality oligos tailored for therapeutic and diagnostic applications. Oligo Factory operates a proprietary synthesis technology that allows for rapid production and scalability, catering to the needs of life sciences customers. Their offerings include research-use-only (RUO) oligos and Good Manufacturing Practice (GMP) compliant oligos, which are crucial for clinical applications. The company emphasizes customer service, providing personalized consultations and support throughout the synthesis process. Oligo Factory's commitment to quality is reflected in their adherence to stringent quality management systems, ensuring that their products meet the high standards required in the biotechnology industry.

23. Clinical Enterprise

• Website: clinicalenterprise.com
• Ownership type: Private
• Headquarters: Framingham, Massachusetts, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2020
• Headcount: 51-200
• LinkedIn: clinical-enterprise

Clinical Enterprise, founded in 2020 and based in Framingham, Massachusetts, is a private biotechnology service provider that specializes in genomic sequencing and genotyping services. The company caters to a variety of clients, including researchers, clinical laboratories, and biopharma companies, offering advanced laboratory solutions that support research and development efforts. Their services include whole genome sequencing, whole exome sequencing, and targeted resequencing, among others. Clinical Enterprise is also known for its customizable data integration capabilities, which enhance the efficiency of data delivery and analysis. The company operates a CLIA-certified and CAP-accredited laboratory, ensuring high standards in their testing processes. With a focus on innovation and collaboration, Clinical Enterprise is positioned to contribute significantly to the bioinformatics field.

Bioinformatics Companies Insights: Key Companies in Massachusetts

Want to Find More Bioinformatics Companies Companies?

With Inven you'll also get to know the company's:

• Detailed Ownership: Who owns the company? Is it a public or private company? What is the ownership structure?
• Contact data: Who are the founders and CEO's? What are their emails and phone numbers?
• Financials: How do these companies perform financially? What are their revenues and profit margins?

...and a lot more!